331. 特発性多中心性キャッスルマン病 Idiopathic multicentric castleman disease Clinical trials / Disease details


臨床試験数 : 33 薬物数 : 46 - (DrugBank : 25) / 標的遺伝子数 : 31 - 標的パスウェイ数 : 155

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2100048364
2021-09-012021-07-06A single-arm, prospective, and multicenter study of rituximab combined with lenalidomide in Castleman diseaseA single-arm, prospective, and multicenter study of rituximab combined with lenalidomide in Castleman disease Castleman diseaseTreatment group:Rituximab+lenalidomide;Department of Hematology, Jiangsu Provincial People's HospitalNULLPending1490BothTreatment group:20;Phase 4China